News Digest
CAC2 Childhood Cancer Community News Digest (July 22-28)
Assorted News from the Last Week: CAC2 Supporting Member Day One Biopharmaceutical and Ipsen unveiled an ex-U.S. licensing agreement for tovorafenib (approved as Ojemda in
July 29, 2024
No Comments
